ARCHIVES

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

This article is from The Cancer Letter archive.

Vol. 29 No. 42 | November 14, 2003

Download PDF Visit The Full Archive

Related Articles

Costs of Rosenberg Regimen Could Hinder cooperative Group Trials

January 3, 1986

In Brief: IU Cancer Center To Receive $15 Million for Breast Cancer

January 31, 2014

Program Announcements

July 25, 1986

New Research Grant Awards

December 13, 1974

FASEB: Focus on Research Funding, Not PR

June 14, 2013

Funding Opportunities

October 18, 2002